Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF
178 results:

  • 1. Effect of gender discordance on surgical outcomes in predominantly female patient surgeries in NYS.
    Smolkin C; Zhang X; Sethi I; Torres A; Yang J; Spaniolas K; Pryor AD
    Surg Endosc; 2024 Mar; 38(3):1556-1567. PubMed ID: 38151678
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Screening and validation of the optimal panel of reference genes in colonic epithelium and relative cancer cell lines.
    Hu Y; Jiang Q; Zhai X; Liu L; Hong Y
    Sci Rep; 2023 Oct; 13(1):17777. PubMed ID: 37853035
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Fertility preservation in reproductive-aged female patients with colorectal cancer: a scoping review.
    Landay SL; Burns JA; Bickle ML; Baltich Nelson B; Nipp RD
    Support Care Cancer; 2023 Oct; 31(10):612. PubMed ID: 37796328
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Selective prediction for extracting unstructured clinical data.
    Swaminathan A; Lopez I; Wang W; Srivastava U; Tran E; Bhargava-Shah A; Wu JY; Ren AL; Caoili K; Bui B; Alkhani L; Lee S; Mohit N; Seo N; Macedo N; Cheng W; Liu C; Thomas R; Chen JH; Gevaert O
    J Am Med Inform Assoc; 2023 Dec; 31(1):188-197. PubMed ID: 37769323
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Real-World Treatment Sequencing in Vulnerable Patients with Metastatic colorectal cancer: A Multicenter Retrospective Study.
    Mitani S; Kito Y; Hino K; Kawakami K; Izawa N; Hanamura F; Yamamoto Y; Shoji H; Komori A; Boku S; Tsuchihashi K; Kato K; Nonagase Y; Matsumoto T; Furuta M; Kawakami H
    Target Oncol; 2023 Sep; 18(5):707-715. PubMed ID: 37668815
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Fovea-UNet: detection and segmentation of lymph node metastases in colorectal cancer with deep learning.
    Liu Y; Wang J; Wu C; Liu L; Zhang Z; Yu H
    Biomed Eng Online; 2023 Jul; 22(1):74. PubMed ID: 37479991
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The effect of numeric information about the likelihood of receiving a false negative or false positive result on people's attitudes towards colorectal cancer screening using faecal immunochemical testing (FIT).
    Miles A; Paschalidi A; Sharma N
    Patient Educ Couns; 2023 Sep; 114():107857. PubMed ID: 37348310
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The effect of mechanical bowel preparation on postoperative complications in laparoscopic right colectomy: a retrospective propensity score matching analysis.
    Perets M; Yellinek S; Carmel O; Boaz E; Dagan A; Horesh N; Reissman P; Freund MR
    Int J Colorectal Dis; 2023 May; 38(1):133. PubMed ID: 37193834
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Maintenance therapy with Fluoropyrimidine and cetuximab or bevacizumab after first line FOLFOX-chemotherapy in metastatic colorectal cancer according to RAS or BRAF
    Kang S; Lee MW; Song IC; Lee HJ; Yun HJ; Jo DY; Kim JS; Kwon JH; Kim JY; Lee KH; Ryu H
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7819-7829. PubMed ID: 37031435
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer.
    Punt CJA; Heinemann V; Maughan T; Cremolini C; Van Cutsem E; McDermott R; Bodoky G; André T; Osterlund P; Teske AJ; Pfeiffer P
    ESMO Open; 2023 Apr; 8(2):101199. PubMed ID: 37018874
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Can frailty scores predict the incidence of cancer? Results from two large population-based studies.
    Mak JKL; Kuja-Halkola R; Wang Y; Hägg S; Jylhävä J
    Geroscience; 2023 Jun; 45(3):2051-2064. PubMed ID: 36997701
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
    Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
    Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT).
    Lombardi P; Aimar G; Peraldo-Neia C; Bonzano A; Depetris I; Fenocchio E; Filippi R; Quarà V; Milanesio M; Cavalloni G; Gammaitoni L; Basiricò M; Cagnazzo C; Ostano P; Chiorino G; Aglietta M; Leone F
    Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562382
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Different neoadjuvant therapies for locally advanced rectal cancer: A systematic review and network meta-analysis.
    Petrelli F; Trevisan F; Tomasello G; De Stefani A; Viti M; Garrone O; Luciani A; Ghidini M
    Crit Rev Oncol Hematol; 2022 Dec; 180():103853. PubMed ID: 36252747
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Residence near industrial complex and cancer incidence: A registry-based cohort of 1,022,637 participants with a follow-up of 21 years, Israel.
    Kayyal-Tarabeia I; Blank M; Zick A; Agay-Shay K
    Environ Res; 2023 Jan; 216(Pt 1):114471. PubMed ID: 36208787
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression.
    Chen S; Li X; Li Y; Yuan X; Geng C; Gao S; Li J; Ma B; Wang Z; Lu W; Hu HG
    Theranostics; 2022; 12(15):6665-6681. PubMed ID: 36185610
    [No Abstract]    [Full Text] [Related]  

  • 17. MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAF
    Tabernero J; Grothey A; Arnold D; de Gramont A; Ducreux M; O'Dwyer P; Tahiri A; Gilberg F; Irahara N; Schmoll HJ; Van Cutsem E
    ESMO Open; 2022 Oct; 7(5):100559. PubMed ID: 36029653
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
    Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
    Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical significance and prospective molecular mechanism of NUF2 in gastric cancer exploration: A comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.
    Ge L; Sun Q; Xia L; Xu X
    Medicine (Baltimore); 2022 Jul; 101(26):e29802. PubMed ID: 35777029
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Role of demographics in noninvasive testing for colorectal cancer screening: do targeted cut-off values improve detection?
    Gill I; Shams C; Hanna A; George J; Jamil LH; Patel A
    Minerva Gastroenterol (Torino); 2023 Dec; 69(4):459-469. PubMed ID: 35343664
    [TBL] [Abstract] [Full Text] [Related]  


    of 9.